Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2016 · 10-Q
Revenue$0.00$0.00— vs Q2 2015 Net Income-$2.29M-$2.29MN/M vs Q2 2015 EPS Diluted-$0.02-$0.02N/M vs Q2 2015 Operating Income-$1,530,112N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2016 · filed Aug 12, 2016 · 43 d after period end